2024-11-26 16:24:16
Appendix 4C - Q2 FY23 Quarterly Cash Flow Report
Corporate/ 2023-07-24
Appendix 4C - Q2 FY23 Quarterly Cash Flo...

Highlights: Expanded participation in ATH434 Phase 2 clinical trial with sites opened for recruitment in Australia,the United States,and Ita...

Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers
Corporate/ 2023-07-24
Sirnaomics Accelerates Clinical Developm...

HONG KONG,GERMANTOWN,Md.,and SUZHOU,China,Feb. 1,2023-- Sirnaomics Ltd.(the "Company" or "Sirnaomics", stock code: 2257....

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release